# Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

> **NCT00094627** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 465 (actual)

## Conditions studied

- Primary Insomnia

## Interventions

- **DRUG:** gaboxadol
- **DRUG:** Comparator: placebo (unspecified)

## Key facts

- **NCT ID:** NCT00094627
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 465 (ACTUAL)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094627, "Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00094627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*